Anupam Rasayan Reports FY22 and Q4FY22 Results

by Suman Gupta

FY22 Revenue of ₹10,660 Mn; growth of 31.46% YoY

FY22 Profit After Tax at ₹1,522 Mn; growth of 116.48%

Surat, May , 2022: Anupam Rasayan India Ltd. (BSE- 543275, NSE- ANURAS, ISIN: INE930P01018), one of India’s leading custom synthesis and specialty chemical player, has announced its financial results for the quarter and year ended March 31, 2022.

Financial Highlights for Quarter Ended March 31st, 2022:

• Revenues at ₹3,172 million in Q4FY22 as compared to ₹2,717 million in Q4FY21 – growth of 17% Y-o-Y.

• EBITDA (incl. other revenue) at ₹969 million in Q4FY22 as compared to ₹655 million in Q4FY21 – growth of 48% Y-o-Y.

• Profit After Tax at ₹461 million in Q4FY22 as compared to ₹221 million in Q4FY21 – growth of 108% Y-o-Y.

Financial Highlights for Twelve Months Ended March 31st, 2022:

• Revenues at ₹10,660 million in FY22 as compared to ₹8,109 million in FY21 – growth of 31% Y-o-Y.

• EBITDA (incl. other revenue) at ₹3,121 million in FY22 as compared to ₹2,202 million in FY21 – growth of 42% Y-o-Y.

• Profit After Tax at ₹1,522 million in FY22 as compared to ₹703 million in FY21 – growth of 116% Y-o-Y.

Anand Desai, Managing Director of Anupam Rasayan, commented, “I am pleased to announce that we have delivered a robust year registering a total revenue growth of 29%, mostly driven by a healthy volume ramp-up. With new LOIs getting signed and older ones getting converted into long-term contracts, the visibility for topline growth in the years to come becomes clearer.”

“Further, our foray into Fluorination chemistries, which will drive our next phase of growth has been strengthened by our successful acquisition of Tanfac’s 26% stake. By the means of this acquisition, we look forward to backward integrate our supply chains in this vertical and focus on production of high value -high margin molecules that have application in varied industries which will give us impetus to enhance our margin profile.”

About Anupam Rasayan India Ltd. (ARIL):Anupam Rasayan India Ltd (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the speciality chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Other Specialty Chemicals comprising Specialty Pigment and Dyes, and Polymer Additives. The Company caters to a diverse base of Indian and global customers. It is currently manufacturing products for over 68 domestic and international customers, including 25 multinational companies. The Company operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhagadia, Bharuch with an aggregate installed capacity of about 27,000 MT, as of 31st March 31, 2022. ARIL offers multistep synthesis and undertakes complex chemical reactions technologies, for a diverse base of Indian and global customers. The Company is focussed on developing in-house innovative processes for manufacturing products requiring complex chemistries and achieving cost optimization.